437-33542-52983
2 vaccinations
1 coded response
7 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 329 / FL
- Registered
- 2021-08-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-07-30
Dose 1 — Pfizer-BioNTech
-
2021-08-03
Registered in v-safe
-
2021-08-03
Survey response — days 1–6 daily, dose 1MedDRA: Dyspnoea — Feeling: FairFree text: Difficulty breathingMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-20
Dose 2 — Pfizer-BioNTech
-
2021-08-20
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Fever · Fatigue or tirednessAdult check-in
- 2021-08-21
- 2021-08-22
- 2021-08-23
- 2021-08-24
- 2021-08-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-30 | Pfizer-BioNTech | No |
| 2 | 2021-08-20 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Difficulty breathing
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dyspnoea | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release